Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CHALLENGER LIMITED Major Shareholding Notification 2025

Sep 24, 2025

64641_rns_2025-09-24_538a77fd-3c3f-457a-9669-76881eb1b518.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

==> picture [596 x 97] intentionally omitted <==

Level 2, 5 Martin Place Sydney NSW 2000 Australia GPO Box 3698 Sydney NSW 2001

challenger.com.au

Telephone 02 9994 7000

25 September 2025

The Manager Company Announcements Office ASX Limited 20 Bridge Street SYDNEY NSW 2000

By electronic lodgement

Dear Sir/Madam

Re: Notice of initial substantial holder – Telix Pharmaceuticals Ltd (TLX)

We attach a notice of initial substantial holder in Telix Pharmaceuticals Ltd. This notice is given by Challenger Limited and each of its associated entities named in Annexure 2 to this notice.

Yours faithfully

==> picture [168 x 71] intentionally omitted <==

Linda Matthews Company Secretary

Sydney Level 2, 5 Martin Place, Sydney NSW 2000 Australia, GPO Box 3698 Sydney NSW 2001, Telephone 02 9994 7000 Melbourne Level 19, 31 Queen Street PO Box 297, Flinders Lane, Melbourne VIC 3000 Telephone 02 9994 7000 Brisbane Level 6, 215 Adelaide Street GPO Box 3234, Brisbane QLD 4000 Telephone 07 3136 5400 Perth Level 26, 140 St Georges Terrace, Perth WA 6000 Telephone 08 6466 9613 Adelaide Level 7, Suite 714, 147 Pirie Street, Adelaide SA 5000 Telephone 08 8427 9511

Challenger Limited ABN 85 106 842 371 | Challenger Group Services Pty Limited ABN 91 085 657 307 Challenger Life Company Limited ABN 44 072 486 938 AFSL 234670 | Challenger Investment Partners Limited ABN 29 092 382 842 AFSL 234 678 Challenger Retirement and Investment Services Limited ABN 80 115 534 453 AFSL295642 RSE Licence No. L0001304 Challenger Mortgage Management Pty Ltd ABN 72 087 271 109 | Challenger Securitisation Management Pty Ltd ABN 56 100 346 898 AFSL 244593 Challenger Investment Solutions Management Pty Ltd ABN 63 130 035 353 AFSL 487354

challenger.com.au

Form 603

Corporations Act 2001

Section 671B Notice of initial substantial holder

To
CompanyName/Scheme
Telix Pharmaceuticals Ltd Telix Pharmaceuticals Ltd
ACN/ARSN 616 620 369
1. Details of substantial holder (1)
Name Challenger Limited(and its entities listed in Annexure 2)
ACN/ARSN (if applicable) 106 842 371 (Challenger Limited)
The holder became a substantial holder on 23/09/2025

2. Details of voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows:

Class of securities (4) Number of securities Person's votes (5) Voting power (6)
Ordinary Fully Paid Same aspersons votes 18,096,417 5.35%

3. Details of relevant interests

The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows:

Holder of relevant interest Nature of relevant interest (7) Class and number of securities
Challenger Limited (and its entities listed in
Ordinary Fully Paid securities
18,096,417 Ordinary Fully Paid
Annexure 2) purchased and sold on market and securities
sold via off market transfer by
Challenger Limited (and its entities
listed in Annexure 2) and obtains a
relevant interest by virtue of section
608(3) of the Corporations Act 2001
(Cth).
4. Details of present registered holders
The persons registered as holders of the securities referred to in paragraph 3 above are as follows:
Holder of relevant interest Person entitled to be registered as holder
Registered holder of securities
Class and number of securities
(8)
Challenger Limited (and its entities BNP Paribas Nominees Pty Limited
BNP Paribas Nominees Pty Limited
101,974 (Ordinary Fully Paid)
listed in Annexure 2)
As above HSBC Custody Nominees (Australia) Limited
HSBC Custody Nominees (Australia)
9,915,183 (Ordinary Fully
Limited Paid)
As above Citicorp Nominees Pty Limited
Citicorp Nominees Pty Limited
4,364,777 (Ordinary Fully
Paid)
As above J. P. Morgan Nominees Australia Pty Limited
J. P. Morgan Nominees Australia Pty
3,691,798 (Ordinary Fully
Limited Paid)
As above UBS Nominees Pty Limited
UBS Nominees Pty Limited
22,685 (Ordinary Fully Paid)
5. Consideration
The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows:
Holder of relevant interest Date of acquisition
Consideration (9)
Class and number of securities
Cash Non-cash
Refer Annexure 2 Refer
Refer
Refer
Annexure 1
Annexure 1
Annexure 1
6. Associates
The reasons the persons named in paragraph 3 above are associates of the substantial holder are as follows:
6. Associates
The reasons the persons named in paragraph 3 above are associates of the substantial holder are as follows:
Name and ACN/ARSN (if applicable) Nature of association
N/A N/A
7. Addresses
The addresses ofpersons named in this form are as follows:
Name Address
Challenger Limited (and its entities listed in Level 2, 5 Martin Place, Sydney NSW 2000
Annexure 2)
Signature
print name Linda Matthews capacity Company Secretary of Challenger Limited
sign here date 25/09/2025

DIRECTIONS

(1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 7 of the form.

(2) See the definition of "associate" in section 9 of the Corporations Act 2001.

(3) See the definition of "relevant interest" in section s608 and 671B(7) of the Corporations Act 2001.

(4) The voting shares of a company constitute one class unless divided into separate classes.

(5) The total number of votes attached to all the voting shares in the company or voting interests in the scheme (if any) that the person or an associate has a relevant interest in.

(6) The person's votes divided by the total votes in the body corporate or scheme multiplied by 100.

(7) Include details of:

(a) any relevant agreement or other circumstances by which the relevant interest was acquired. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and

(b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).

See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

(8) If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write "unknown".

(9) Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.

Annexure 1 consists of 1 page/s and is referred to in Form 603 signed by me and dated 25/09/2025

==> picture [110 x 44] intentionally omitted <==

Linda Matthews Company Secretary of Challenger Limited

Transactions:

Company Name/Scheme: Telix Pharmaceuticals Ltd (TLX) As at: 23/09/2025 Class of security: Ordinary Fully Paid

Date of Change Holder of relevant interest Nature of Change Consideration Number of
Securities
Person's Votes
Affected
16/09/2025 Challenger Limited (and its entities listed
in Annexure 2)
Sell 157,307 -11,200 11,200
16/09/2025 As above Sell 348,371 -24,800 24,800
16/09/2025 As above Buy 1,020,039 72,646 72,646
23/09/2025 As above Buy 270,074 16,500 16,500
23/09/2025 As above Buy 1,980,543 121,000 121,000
23/09/2025 As above Buy 3,091,939 188,900 188,900
23/09/2025 As above Buy 548,332 33,500 33,500
23/09/2025 As above Buy 712,013 43,500 43,500
23/09/2025 As above Buy 2,461,766 150,400 150,400
23/09/2025 As above Sell 14,387 -881 881
23/09/2025 As above Sell 29,118 -1,783 1,783
23/09/2025 As above Sell 11,366 -696 696
23/09/2025 As above Sell 23,728 -1,453 1,453
23/09/2025 As above Sell 159,420 -9,762 9,762
23/09/2025 As above Sell 177,531 -10,871 10,871
23/09/2025 As above Sell 63,559 -3,892 3,892
23/09/2025 As above Sell 121,108 -7,416 7,416
23/09/2025 As above Sell 92,448 -5,661 5,661
23/09/2025 As above Sell 219,370 -13,433 13,433
23/09/2025 As above Sell 130,351 -7,982 7,982
23/09/2025 As above Sell 19,107 -1,170 1,170
23/09/2025 As above Buy 2,294,811 140,200 140,200
23/09/2025 As above Buy 1,332,365 81,400 81,400
23/09/2025 As above Buy 5,247,621 320,600 320,600
23/09/2025 As above Buy 504,138 30,800 30,800
23/09/2025 As above Buy 3,417,664 208,800 208,800
23/09/2025 As above Buy 2,049,289 125,200 125,200
23/09/2025 As above Buy 2,332,458 142,500 142,500
23/09/2025 As above Sell - Transfer 4,903,861 -299,381 299,381

Page 1 of 1

Annexure 2

This is page 1 of 2 of Annexure 2 referred to in ASIC Form 603 - becoming a substantial holder

==> picture [106 x 43] intentionally omitted <==

Linda Matthews - Company Secretary of Challenger Limited 25/09/2025

Company Name ACN / Country of
Company Number Incorporation
Challenger Limited 106842371 Australia
255 Finance Group Pty Ltd 628853056 Australia
255 Finance Investments Pty Ltd 164516401 Australia
255 Finance Pty Ltd 168112507 Australia
255 Finance Services Pty Ltd 168107355 Australia
Alphinity Investment Management Pty Ltd 140833709 Australia
Ardea Investment Management Pty Ltd 132902722 Australia
Ardea Investment Management (UK) Limited 13043903 United Kingdom
Artega Investment Administration Pty Limited 661042093 Australia
Bentham Asset Management Pty Ltd 140833674 Australia
Calix Re Holdings Limited 202504686 Bermuda
Calix Re Limited 202504726 Bermuda
Calix Re MidCo Limited 202504725 Bermuda
CDPG Australia Pty Limited 124498095 Australia
Challenger DPG France II SAS 495391062 France
Challenger Financial Services Pty Limited 087464131 Australia
Challenger Funds Management Holdings Pty Limited 107728030 Australia
Challenger Group Holdings Limited 002993302 Australia
Challenger Group Pty Limited 003374196 Australia
Challenger Group Services Pty. Ltd. 085657307 Australia
Challenger Holdco2 Holdings Pty Ltd 646761275 Australia
Challenger Holdco3 Holdings Pty Ltd 657425744 Australia
Challenger Home Loan Corporation Pty Ltd 058891302 Australia
Challenger IM Capital Limited 687738263 Australia
Challenger Investment Partners Limited 092382842 Australia
Challenger Investment Solutions Management Pty Ltd 130035353 Australia
Challenger Japan Holdings Kabushiki Kaisha 0100-01-182399 Japan
Challenger Japan Holdings Pty Limited 617208205 Australia
Challenger Kabushiki Kaisha 0100-01-182872 Unknown
Challenger Life CDI Nominees Pty Ltd 055293644 Australia
Challenger Life Company Holdings Pty Ltd 006381193 Australia
Challenger Life Company Limited 072486938 Australia
Challenger Life Debt Investments (Europe) Limited 7626067 United Kingdom
Challenger Life Fund Property Investments Pty Ltd 161212693 Australia
Challenger Life Nominees No.2 Pty Ltd 078627013 Australia
Challenger Life Nominees No.3 Pty Limited 151482147 Australia
Challenger Life Nominees Pty Ltd 091336793 Australia
Challenger Life Subsidiary Holdings Pty Limited 099742122 Australia
Challenger Management Services (UK) Limited 6393787 United Kingdom
Challenger Mortgage Management Pty Ltd 087271109 Australia
Challenger NZ Holdco1 Limited 9279773 New Zealand
Challenger Non-conforming Finance Pty Ltd 107725486 Australia
Challenger Retirement and Investment Services Limited 115534453 Australia
Challenger Securitisation Management Pty Ltd 100346898 Australia
Challenger Special Servicing Pty Ltd 107707415 Australia
Challenger Treasury Limited 093307996 Australia

Annexure 2

This is page 2 of 2 of Annexure 2 referred to in ASIC Form 603 - becoming a substantial holder

==> picture [106 x 43] intentionally omitted <==

Linda Matthews - Company Secretary of Challenger Limited 25/09/2025

Company Name ACN / Country of
Company Number Incorporation
Challenger Wholesale Finance Holdings Pty Limited 087284240 Australia
Challenger Wind Holdings Pty Limited 151496061 Australia
CLS US Holdings, LLC 5302598 United States
CPHIC Investments Pty Ltd 093340526 Australia
Cultiv8 Carry Services Pty Ltd 661978356 Australia
Cultiv8 Funds Management Pty Ltd 659433593 Australia
Cultiv8 GPCo Pty Ltd 655 779 105 Australia
Eiger Capital Pty Limited 631838607 Australia
Fidante Partners AAM Holdings Pty Limited 636490189 Australia
Fidante Partners AB 559327-5497 Sweden
Fidante Partners Alphinity Holdings Pty Ltd 140716016 Australia
Fidante Partners Ardea Holdings Pty Ltd 133865853 Australia
Fidante Partners Bentham Holdings Pty Ltd 140715573 Australia
Fidante Partners Cultiv8 Holdings Pty Ltd 659373109 Australia
Fidante Partners Eiger Holdings Pty Limited 631837360 Australia
Fidante Partners Europe Limited 4040660 United Kingdom
Fidante Partners FME Holdings Limited 11410594 United Kingdom
Fidante Partners Holdco1 Pty Limited 666942196 Australia
Fidante Partners Holdings (Guernsey) Limited 43315 Guernsey
Fidante Partners Holdings Europe Limited 6172534 United Kingdom
Fidante Partners Holdings Pty Limited 123318650 Australia
Fidante Partners Lennox Holdings Pty Limited 616975565 Australia
Fidante Partners Limited 002835592 Australia
Fidante Partners Liquid Strategies ICAV C139635 Ireland
Fidante Partners Merlon Holdings Pty Ltd 140715662 Australia
Fidante Partners Novaport Holdings Pty Ltd 140715797 Australia
Fidante Partners Ox Holdings Pty Ltd 649174087 Australia
Fidante Partners Services Limited 119605373 Australia
Fidante Partners System Holdings Pty Ltd 678592928 Australia
Fidante Partners Wavestone Holdings Pty Limited 133626276 Australia
Fidante Partners Whitehelm Holdings Pty Ltd 169043903 Australia
FME Asset Management Limited 11064883 United Kingdom
Greencape Capital Pty Ltd 120328529 Australia
Kabushiki Kaisha C & K 0104-01-067168 Japan
Kudu Investment Partners I, Lp 47-2497501 Unknown
Lease Collateral No.2 Pty Ltd 168112481 Australia
Lease Collateral Pty Ltd 168112472 Australia
Lease Funding Management Pty Ltd 168112490 Australia
Lending JV Holdco Pty Ltd 661671683 Australia
Lennox Capital Partners Pty Limited 617001966 Australia
Novaport Capital Pty Ltd 140833656 Australia
Oaklands Hill Pty Ltd 149814559 Australia
Oaklands Hill Wind Farm Pty Ltd 126595935 Australia
Offshore Reinsurer (Bermuda) Company Limited 51746 Bermuda
Ox Capital Management Pty Ltd 648887914 Australia
Ox Capital Management HK Pty. Limited 76656681 Hong Kong
Resonance Asset Management Limited 9028327 United Kingdom
System Capital Pty Ltd 657739323 Australia
System Holdings Pty Ltd 657737276 Australia
US LLC Holdings Pty Ltd 130888292 Australia
US LLC Investments LLC 36-4811214 United States
Water Ventures Limited 9592184 United Kingdom
Wavestone Capital Pty Limited 120179419 Australia